CCR2 and Autoimmunity: Similarly, the Mildner study showed that the selective depletion of CCR2+Ly6Chi monocytes strongly reduced the CNS autoimmunity, indicating a disease-promoting role of CCR2+Ly6Chi monocytes during autoimmune inflammation of the CNS [54].